Addex Therapeutics Investor Relations Material

Addex Therapeutics Ltd is a biotechnology company focused on the discovery and development of small molecule therapies for neurological disorders. The company specializes in allosteric modulators, a drug discovery approach aimed at targeting specific receptors in the central nervous system to treat conditions such as Parkinson’s disease, epilepsy, and schizophrenia. Addex conducts clinical and preclinical research to advance its pipeline of investigational treatments. The company is headquartered in Geneva, Switzerland, and its shares are listed on the SIX Swiss Exchange.